BMC3PM:个性化精密医学的生物信息学多药组合协议及其在癌症治疗中的应用
Majid Mokhtari1, Samane Khoshbakht2,3, Mohammad Esmaeil Akbari4
1Department of Bioinformatics, Kish International Campus, University of Tehran, Kish Island, Iran. majid.mokhtari@ut.ac.ir.
BMC medical genomics
|December 13, 2023
概括
这项研究引入了针对癌症治疗的个性化药物组合协议,利用个体基因表达模式来选择有效的药物组合. 这种方法通过改善癌症患者的药物验证和安全测试来增强个性化医疗.
科学领域:
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 个性化医疗在癌症治疗药物查方面面临挑战.
- 新平台为个性化药物验证和安全测试提供解决方案.
- 为这些平台开发了一种新的个性化药物组合协议.
研究的目的:
- 开发一种针对癌症治疗的个性化药物组合方案.
- 利用全基因组表达数据进行个性化药物选择.
- 将药物重用与组合药物治疗相结合.
主要方法:
- 利用6173名乳腺癌患者和691种药物的全基因表达特征.
- 为每个患者开发了个别的扰乱基因表达 (IPPGE) 模式.
- 设计了一种算法,通过比较IPPGE和药物签名来提取个性化的药物组合,并结合了药物重用.
主要成果:
- 从专门和非专门的癌症药物中组合药物显示出更高的疗效.
- 发现每个患者的扰乱基因表达 (IPPGE) 个体模式都是独一无二的.
- 该协议有效地从大量选项中提取个性化的药物组合.
结论:
- 开发的协议作为一种方法界面,用于癌症中药物重用和组合治疗.
- 它可以提取个性化的药物组合,提供潜在的更有效的治疗选择.
- 这种方法推进了个性化药物验证和瘤学安全性测试.
更多相关视频
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K